PIK3CA and neoplasm: In particular an interesting study showed that high infiltration of tumor associated myeloid cells induced resistance to immune checkpoint blockade; while selective pharmacologic targeting of PI3K-Υ, highly expressed in myeloid cells, restored the sensitivity to immune check point agents by switching the tumor microenvironment to a pro-inflammatory phenotype [106].